SecBot SecBot
6-K ·Filed Mar 30, 2026

RYLPF

KONINKLIJKE PHILIPS NV
NEUTRAL
Impact 3/10
Horizonweeks Processed7mo ago SEC0001628280-26-021906
Notable filing: 6-K
Actionable Insight • Neutral

No trading implications from this filing alone; monitor AGM outcomes for dividend declaration and any unexpected governance votes, but leadership continuity is confirmed.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d ⚠ clustered
RYLPF ▼ -1.01% at T+60d
NEUTRAL call -1.01% · α vs SPY -17.50% · entry $26.46 → $26.19
Entry = T+0 close
Mar 30, 2026
via day close
T+1d
0.00%
call 0.00% · α -2.89%
$26.46
settled 7mo ago
T+5d
+2.98%
call +2.98% · α -1.32%
$27.25
settled 7mo ago
T+20d
+4.88%
call +4.88% · α -7.71%
$27.75
settled 6mo ago
T+60d
-1.01%
call -1.01% · α -17.50%
$26.19
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Royal Philips convened its 2026 Annual General Meeting of Shareholders, announcing board appointments and re-appointments, including Roy Jakobs as CEO, and公布了 agenda items such as financial statements adoption and dividend proposals. This is a routine corporate governance filing.

Key Facts

  • Philips convened its Annual General Meeting of Shareholders on May 8, 2026.
  • John DeFord appointed as new member of the Supervisory Board effective May 8, 2026.
  • Roy Jakobs re-appointed as President, CEO, and Chairman of the Board of Management.
  • Paul Stoffels, Herna Verhagen, and Sanjay Poonen re-appointed to the Supervisory Board.
  • Agenda includes adoption of 2025 financial statements, dividend proposal (cash or shares), and remuneration policy vote.

Financial Impact

No immediate financial impact; dividend decision pending shareholder vote.

dividendexecutive leadershipgovernance

Risk Factors

  • Potential shareholder dissent on remuneration policy could signal governance concerns, though not indicated here.
  • Dividend payout in shares vs. cash could impact share count and investor sentiment if announced.

Market Snapshot

Exchange
OTC
Sector
X-Ray Apparatus & Tubes & Related Irradiation Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001628280-26-021906
Document: 0001628280-26-021906-index-headers.html0001628280-26-021906
Document: 0001628280-26-021906-index.html0001628280-26-021906
Document: 0001628280-26-021906.txt0001628280-26-021906
4 reports for RYLPF
Performance horizon
Filters
Rows
Reports for RYLPF — sortable, filterable
TypeNow
Jun 2, 2026
20w ago
6-K
NEUTRAL ★ 2/10
$25.44 $26.19▲ +2.94%▲ +4.50%$26.50 (+4.15%)
May 8, 2026
24w ago
6-K
NEUTRAL ★ 2/10
$26.93 $26.06▼ −3.21%▼ −3.23%$26.50 (−1.59%)
Mar 30, 2026
30w ago
6-K
NEUTRAL ★ 3/10
$26.46 $27.75▲ +4.88%▼ −7.71%$26.50 (+0.16%)
Mar 30, 2026
30w ago
6-K
NEUTRAL ★ 3/10
$26.46 $27.75▲ +4.88%▼ −7.71%$26.50 (+0.16%)
Showing 4 of 4

US Market Status

Market Open — Closes in 1h 48m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 30, 2026